A multidisciplinary management pathway for patients with metabolic associated fatty liver disease
10.3760/cma.j.cn501113-20250604-00217
- VernacularTitle:代谢相关脂肪性肝病患者多学科管理路径
- Author:
Xiaobo CAI
1
;
Lungen LU
1
Author Information
1. 上海交通大学医学院附属第一人民医院消化内科，上海 200080
- Publication Type:Journal Article
- Keywords:
Metabolic associated fatty liver disease;
Multidisciplinary team;
Diagnosis;
Therapeutic;
Prognosis;
Management
- From:
Chinese Journal of Hepatology
2025;33(9):822-825
- CountryChina
- Language:Chinese
-
Abstract:
Metabolic associated fatty liver disease (MAFLD) has replaced non-alcoholic fatty liver disease (NAFLD), emphasizing the core role of metabolic dysfunctions and necessitating a multidisciplinary (MDT) approach for diagnosis and treatment to concurrently manage liver disease and metabolic disorders.Downplaying the non-alcohol label while focusing more on metabolic driving factors allows it to coexist with other liver diseases. The gastroenterology and hepatology department is the initial assessment department, and MDT, which includes endocrinology, nutrition, sports medicine, surgery, and psychology, develops individualized treatment plans. With the aim of halting the progression of the disease (steatosis → fibrosis → cirrhosis) and eventually improving patient prognosis, MAFLD management must be based on metabolic intervention and accomplish "liver disease metabolic co-treatment" through multidisciplinary integration.
